201 related articles for article (PubMed ID: 20840279)
1. Hormonal contraception in obesity, the metabolic syndrome, and diabetes.
Skouby SO
Ann N Y Acad Sci; 2010 Sep; 1205():240-4. PubMed ID: 20840279
[TBL] [Abstract][Full Text] [Related]
2. Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091.
; Higginbotham S
Contraception; 2009 Dec; 80(6):583-90. PubMed ID: 19913155
[TBL] [Abstract][Full Text] [Related]
3. Obesity and hormonal contraception: safety and efficacy.
Edelman AB; Jensen JT
Semin Reprod Med; 2012 Dec; 30(6):479-85. PubMed ID: 23074006
[TBL] [Abstract][Full Text] [Related]
4. [Contraception in women with diabetes mellitus].
Nikolov A; Dimitrov A; Kolarov G; Todarova K; Mekhandzhiev Ts
Akush Ginekol (Sofiia); 2005; 44(5):47-52. PubMed ID: 16313055
[TBL] [Abstract][Full Text] [Related]
5. Hormonal contraception in women with the metabolic syndrome: a narrative review.
Verhaeghe J
Eur J Contracept Reprod Health Care; 2010 Oct; 15(5):305-13. PubMed ID: 20695771
[TBL] [Abstract][Full Text] [Related]
6. [Options of hormonal contraceptives and substitution in female diabetic patients].
Sadlonová J
Vnitr Lek; 2009 Apr; 55(4):375-83. PubMed ID: 19449754
[TBL] [Abstract][Full Text] [Related]
7. Relationship of metabolic risk factors and development of cardiovascular disease and diabetes.
Haffner SM
Obesity (Silver Spring); 2006 Jun; 14 Suppl 3():121S-127S. PubMed ID: 16931493
[TBL] [Abstract][Full Text] [Related]
8. Effects of lifestyle intervention and metformin on weight management and markers of metabolic syndrome in obese adolescents.
Harden KA; Cowan PA; Velasquez-Mieyer P; Patton SB
J Am Acad Nurse Pract; 2007 Jul; 19(7):368-77. PubMed ID: 17680902
[TBL] [Abstract][Full Text] [Related]
9. Obesity and sexual dysfunction, male and female.
Esposito K; Giugliano F; Ciotola M; De Sio M; D'Armiento M; Giugliano D
Int J Impot Res; 2008; 20(4):358-65. PubMed ID: 18401349
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of metabolic syndrome in the Mediterranean region of Turkey: evaluation of hypertension, diabetes mellitus, obesity, and dyslipidemia.
Gündogan K; Bayram F; Capak M; Tanriverdi F; Karaman A; Ozturk A; Altunbas H; Gökce C; Kalkan A; Yazici C
Metab Syndr Relat Disord; 2009 Oct; 7(5):427-34. PubMed ID: 19754305
[TBL] [Abstract][Full Text] [Related]
11. Obesity and the polycystic ovary syndrome.
Martínez-Bermejo E; Luque-Ramírez M; Escobar-Morreale HF
Minerva Endocrinol; 2007 Sep; 32(3):129-40. PubMed ID: 17912153
[TBL] [Abstract][Full Text] [Related]
12. Maternal obesity and pregnancy.
Satpathy HK; Fleming A; Frey D; Barsoom M; Satpathy C; Khandalavala J
Postgrad Med; 2008 Sep; 120(3):E01-9. PubMed ID: 18824817
[TBL] [Abstract][Full Text] [Related]
13. Obesity and contraception: emerging issues.
Murthy AS
Semin Reprod Med; 2010 Mar; 28(2):156-63. PubMed ID: 20352564
[TBL] [Abstract][Full Text] [Related]
14. Fetal exposure to gestational diabetes contributes to subsequent adult metabolic syndrome.
Moore TR
Am J Obstet Gynecol; 2010 Jun; 202(6):643-9. PubMed ID: 20430355
[TBL] [Abstract][Full Text] [Related]
15. [The polycystic ovary syndrome--metabolic consequences].
Tan S; Hahn S; Janssen OE
Gynakol Geburtshilfliche Rundsch; 2008; 48(1):16-23. PubMed ID: 18209495
[No Abstract] [Full Text] [Related]
16. [The obese woman: pregnancy and contraception].
Seffert P
Lyon Mediterr Med Med Sud Est; 1985 Oct; 21(16):10179-80. PubMed ID: 12282289
[TBL] [Abstract][Full Text] [Related]
17. Factors related to planned and unplanned pregnancies.
Rosenfeld JA; Everett KD
J Fam Pract; 1996 Aug; 43(2):161-6. PubMed ID: 8708626
[TBL] [Abstract][Full Text] [Related]
18. [Oral contraception, glucid metabolism and monitoring criteria].
Gaspard U
Contracept Fertil Sex (Paris); 1988 Feb; 16(2):113-8. PubMed ID: 12342000
[TBL] [Abstract][Full Text] [Related]
19. Obesity and the metabolic syndrome in the elderly--a mini-review.
Lechleitner M
Gerontology; 2008; 54(5):253-9. PubMed ID: 18841025
[TBL] [Abstract][Full Text] [Related]
20. Increasing prevalence of obesity and clustered cardiometabolic risk: can treatment of the underlying cause reverse the trends?
Ballantyne CM
Crit Pathw Cardiol; 2007 Jun; 6(2):41-5. PubMed ID: 17667863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
